Verona Pharma sets sights on COPD treatment with FDA review By Investing.com
© Reuters. Verona Pharma PLC (NASDAQ:) has introduced throughout its This autumn and full-year 2023 earnings name that the U.S. ...
Tag: sights
© Reuters. Verona Pharma PLC (NASDAQ:) has introduced throughout its This autumn and full-year 2023 earnings name that the U.S. ...